Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis
Background For rheumatoid arthritis (RA), the HLA-DRB1 ‘shared epitope’ (SE) allele has been proposed as a predictive biomarker for the effectiveness of mainly abatacept and other biologic disease-modifying antirheumatic drugs (bDMARDs).Objective To explore the relative impact of SE positivity on th...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2026-07-01
|
| Saila: | RMD Open |
| Sarrera elektronikoa: | https://rmdopen.bmj.com/content/12/3/e006788.full |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
